TP53 and neoplasm: Genetic deletion of USP28 via CRISPR/Cas9 blocked tumour formation in a mouse model of lung squamous cell carcinoma (LSCC) driven by mutant KrasG12D in combination with deletion of Trp53 and Lkb1 [16].